On November 17, 2025, the UK National Screening Committee (UK NSC) launched a consultation on the 2025 evidence map relating to population screening for bladder cancer, which is not currently recommended in the UK. The evidence review found no substantial new evidence to change existing recommendations or commissioning further evidence synthesis work. The topic should be reconsidered by the UK NSC in three years. Organizations and the public are invited to submit comments until February 9, 2026.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Mezei et al. examined regulatory and methodological barriers affecting digital health technologies, drawing on surveys, interviews, and focus groups with developers from ten European countries.

On November 7, 2025, the Health Reform Partnership held a meeting, comprising representatives from the federal states, the social insurance system, the Association of Cities and Municipalities, and the governing parties. It was agreed that the federal government and the states are jointly assuming responsibility for a comprehensive reform agenda.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Choi et al. explored the concept of heterogeneity in meta-analyses, aiming to review the main sources of heterogeneity between studies and how it shapes pooled estimates.

On November 13, 2025, the National Association of Statutory Health Insurance Physicians (KBV) announced that the 2026 Hybrid DRGs catalog had been approved. A total of 47 new Hybrid DRGs were added, including those for appendectomy, cholecystectomy, as well as minimally invasive procedures on the coronary arteries and peripheral vessels. In the area of orthopedic procedures, Hybrid DRGs have been expanded to include fracture osteosynthesis

In late October 2025, the Decision Forum for the "New Methods" framework made a favorable coverage decision for magnetic resonance-guided high-intensity focused ultrasound (MRgFUS, ExAblate Neuro by Insightec) for the treatment of essential tremor.

On November 17, 2025, NHS England published a draft 2026/27 NHS Payment Scheme (NHSPS) and launched a consultation. While the overall payment model remains, some specific changes are proposed, including new blended payments for urgent and emergency care, radiotherapy, and genomic testing, as well as two new Best Practice Tariffs (BPT) to incentivize day case procedures, and 10 Year Health Plan referral-to-treatment (RTT) priorities. The deadline for comment submission is December 16, 2025.

MTRC, a leading boutique Med Tech market access consultancy in Europe, is looking for a Director of Market Access and HEOR.

In October 2025, Health Technology Wales (HTW) accomplished two full appraisals on digital interventions for chronic kidney disease and at-home video monitoring for the diagnosis and management of epilepsy. Additionally, six Med Tech-related Topic Exploration Reports were published in the IVD, e-health, gastrointestinal, and endoscopy fields.

MTRC is seeking a Junior Research Fellow to contribute to our evidence synthesis projects, including systematic reviews and value dossiers, in the evolving field of medical devices. Work is purely analytical, no hands-on/clinical/lab work is involved.

MTRC is looking for an experienced Health Economist to work on international health economic projects in the field of medical devices.

MTRC is looking for a Senior Health Economist to work on international health economic projects in the field of medical devices.